0

Hemostats and Tissue Sealants Market by Product and Geography - Forecast and Analysis 2022-2026

  • Published: Jul 2022
  • Pages: 139
  • SKU: IRTNTR40802
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

The hemostats and tissue sealants market share is expected to increase to USD 2.24 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 9.82%.

This hemostats and tissue sealants market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers hemostats and tissue sealants market segmentation by product (hemostats, tissue sealants and adhesives, and fibrin sealants) and geography (Europe, APAC, North America, South America, and Middle East and Africa). The hemostats and tissue sealants market report also offers information on several market vendors, including Advanced Medical Solutions Group Plc, Artivion Inc., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Biomup SA, Cardinal Health Inc., CSL Ltd., Hemostasis LLC, Integra Lifesciences Holdings Corp., Johnson and Johnson, KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., and Vivostat AS among others.

What will the Hemostats and Tissue Sealants Market Size be During the Forecast Period?

Hemostats and Tissue Sealants Market Size

Download the Free Report Sample to Unlock the Hemostats and Tissue Sealants Market Size for the Forecast Period and Other Important Statistics

 

Hemostats and Tissue Sealants Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The use of hemostats and tissue sealants in surgeries is notably driving the hemostats and tissue sealants market growth, although factors such as the high cost of hemostats and tissue sealants may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the hemostats and tissue sealants industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Hemostats and Tissue Sealants Market Driver

One of the key factors driving the global hemostats and tissue sealants market growth is the use of hemostats and tissue sealants in surgeries. Every month, nearly 25 million surgeries are performed worldwide. Using hemostats in surgeries helps reduce blood loss, while the use of surgical sealants can help seal suture lines and prevent leaks. The use of hemostats helps achieve hemostasis in a shorter time, inflicts lesser pain to patients, and does not require removal. Hemostats and tissue sealants are finding increased applications in minimally invasive surgeries. Nearly 950,000 laparoscopic surgeries are performed every year in the US and Europe alone. Thus, the intraoperative use of hemostatic agents and tissue sealants has significantly increased in minimally invasive surgeries and percutaneous interventional procedures. Owing to such factors, the market is expected to grow during the forecast years.

Key Hemostats and Tissue Sealants Market Trend

Increasing R&D focus on novel hemostats and tissue sealants is one of the key hemostats and tissue sealants market trends that is expected to impact the industry positively in the forecast period. Some examples of the same are as follows:

  • Between 2020 and 2023, Baxter International plans to launch a range of next-generation hemostats and sealants and their advanced delivery systems.
  • 3-D Matrix Medical Technology is focusing its R&D efforts on the development of synthetic hemostatic material in the form of a prefilled syringe called PuraStat.
  • Endomedix Inc. (Endomedix), a private biotechnology company, focuses on the development of a series of absorbable hemostats for military, surgical, and first responder applications. The company plans to pursue intracranial or brain surgery as its targeted first indication use for its absorbable hemostats.

Many new products may enter the market during the forecast period, which will further support the market growth.

Key Hemostats and Tissue Sealants Market Challenge

One of the key challenges to the global hemostats and tissue sealants market growth is the high cost of hemostats and tissue sealants. Some examples of the same are as follows:

  • On average, the per-unit cost of fibrin sealants ranges from $50 to $600.
  • The per-unit cost of mechanical hemostats ranges from $50 to $200.
  • The per-unit cost of active flowable ranges from $200 to $300.

 Also, several developing economies with limited healthcare budgets do not provide insurance coverage for hemostats and tissue sealants. Apart from the cost of hemostats and tissue sealants, patients must also bear the costs of surgeons and nursing time. In some cases, patients might require multiple procedures, long hospital stays, long-term rehabilitation, and material-intensive surgical and nonsurgical care. Such factors may hinder market growth in the coming years.

This hemostats and tissue sealants market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global hemostats and tissue sealants market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the hemostats and tissue sealants market during the forecast period.

Who are the Major Hemostats and Tissue Sealants Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Advanced Medical Solutions Group Plc
  • Artivion Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • BioCer Entwicklungs GmbH
  • Biomup SA
  • Cardinal Health Inc.
  • CSL Ltd.
  • Hemostasis LLC
  • Integra Lifesciences Holdings Corp.
  • Johnson and Johnson
  • KATSAN KATGUT SANAYI VE TICARET A.S
  • Medtronic Plc
  • Pfizer Inc.
  • Stryker Corp.
  • Teijin Ltd.
  • Teleflex Inc.
  • Tricol Biomedical Inc.
  • Vivostat AS

 

This statistical study of the hemostats and tissue sealants market encompasses successful business strategies deployed by the key vendors. The hemostats and tissue sealants market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

  • Advanced Medical Solutions Group Plc - The company offers hemostats and tissue sealants under the brands Liquiband, Activheal, and Resorba. 
  • Artivion Inc. - The company offers hemostats and tissue sealants such as PerClot polysaccharides. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The hemostats and tissue sealants market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Hemostats and Tissue Sealants Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the hemostats and tissue sealants market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Hemostats and Tissue Sealants Market?

Hemostats and Tissue Sealants Market Share by Geography

For more insights on the market share of various regions Request for a FREE sample now!

46% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for hemostats and tissue sealants in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The availability of advanced healthcare infrastructure and the rising number of surgical procedures will facilitate the hemostats and tissue sealants market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of the COVID-19 pandemic in North America led to the imposition of lockdowns. However, the market in focus recovered in 2021 due to the lifting of lockdowns and the initiation of large-scale vaccination drives. Moreover, vendors are trying to introduce new products in the market that can cater to the specific needs of healthcare facilities triggered by the pandemic. Such factors are expected to increase the demand for hemostats and tissue sealants in North America during the forecast period.

What are the Revenue-generating Product Segments in the Hemostats and Tissue Sealants Market?

Hemostats and Tissue Sealants Market Share

To gain further insights on the market contribution of various segments Request for a FREE sample

The hemostats and tissue sealants market share growth by the hemostats segment will be significant during the forecast period. It is a medical device used to achieve hemostasis by accelerating the clotting of blood. Hemostats are mainly classified into four categories, namely mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants. The growth of the segment will be driven by the increasing demand for hemostats in surgical procedures and the growing awareness of the clinical benefits of hemostats. Furthermore, several vendors are increasing their R&D focus on developing technologically advanced hemostats.

This report provides an accurate prediction of the contribution of all the segments to the growth of the hemostats and tissue sealants market size and actionable market insights on post COVID-19 impact on each segment.

 

Hemostats and Tissue Sealants Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 9.82%

Market growth 2022-2026

$ 2.24 billion

Market structure

Fragmented

YoY growth (%)

9.3

Regional analysis

Europe, APAC, North America, South America, and Middle East and Africa

Performing market contribution

North America at 46%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Advanced Medical Solutions Group Plc, Artivion Inc., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Biomup SA, Cardinal Health Inc., CSL Ltd., Hemostasis LLC, Integra Lifesciences Holdings Corp., Johnson and Johnson, KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., and Vivostat AS

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Hemostats and Tissue Sealants Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive hemostats and tissue sealants market growth during the next five years
  • Precise estimation of the hemostats and tissue sealants market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the hemostats and tissue sealants industry across Europe, APAC, North America, South America, and Middle East and Africa
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of hemostats and tissue sealants market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 Hemostats - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Hemostats - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Hemostats - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Hemostats - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Hemostats - Year-over-year growth 2021-2026 (%)
    • 5.4 Tissue sealants and adhesives - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Tissue sealants and adhesives - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Tissue sealants and adhesives - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Tissue sealants and adhesives - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Tissue sealants and adhesives - Year-over-year growth 2021-2026 (%)
    • 5.5 Fibrin sealants - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Fibrin sealants - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Fibrin sealants - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Fibrin sealants - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Fibrin sealants - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by Product
      • Exhibit 40: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Canada - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.9 Germany - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.10 UK - Market size and forecast 2021-2026
      • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.11 China - Market size and forecast 2021-2026
      • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 82: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 85: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 86: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 87: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 88: Matrix on vendor position and classification
            • 10.3 Advanced Medical Solutions Group Plc
              • Exhibit 89: Advanced Medical Solutions Group Plc - Overview
              • Exhibit 90: Advanced Medical Solutions Group Plc - Business segments
              • Exhibit 91: Advanced Medical Solutions Group Plc - Key offerings
              • Exhibit 92: Advanced Medical Solutions Group Plc - Segment focus
            • 10.4 Artivion Inc.
              • Exhibit 93: Artivion Inc. - Overview
              • Exhibit 94: Artivion Inc. - Business segments
              • Exhibit 95: Artivion Inc. - Key offerings
              • Exhibit 96: Artivion Inc. - Segment focus
            • 10.5 B. Braun SE
              • Exhibit 97: B. Braun SE - Overview
              • Exhibit 98: B. Braun SE - Business segments
              • Exhibit 99: B. Braun SE - Key news
              • Exhibit 100: B. Braun SE - Key offerings
              • Exhibit 101: B. Braun SE - Segment focus
            • 10.6 Baxter International Inc.
              • Exhibit 102: Baxter International Inc. - Overview
              • Exhibit 103: Baxter International Inc. - Business segments
              • Exhibit 104: Baxter International Inc. - Key news
              • Exhibit 105: Baxter International Inc. - Key offerings
              • Exhibit 106: Baxter International Inc. - Segment focus
            • 10.7 Becton Dickinson and Co.
              • Exhibit 107: Becton Dickinson and Co. - Overview
              • Exhibit 108: Becton Dickinson and Co. - Business segments
              • Exhibit 109: Becton Dickinson and Co. - Key news
              • Exhibit 110: Becton Dickinson and Co. - Key offerings
              • Exhibit 111: Becton Dickinson and Co. - Segment focus
            • 10.8 Integra Lifesciences Holdings Corp.
              • Exhibit 112: Integra Lifesciences Holdings Corp. - Overview
              • Exhibit 113: Integra Lifesciences Holdings Corp. - Business segments
              • Exhibit 114: Integra Lifesciences Holdings Corp. - Key news
              • Exhibit 115: Integra Lifesciences Holdings Corp. - Key offerings
              • Exhibit 116: Integra Lifesciences Holdings Corp. - Segment focus
            • 10.9 Johnson and Johnson
              • Exhibit 117: Johnson and Johnson - Overview
              • Exhibit 118: Johnson and Johnson - Business segments
              • Exhibit 119: Johnson and Johnson - Key news
              • Exhibit 120: Johnson and Johnson - Key offerings
              • Exhibit 121: Johnson and Johnson - Segment focus
            • 10.10 Medtronic Plc
              • Exhibit 122: Medtronic Plc - Overview
              • Exhibit 123: Medtronic Plc - Business segments
              • Exhibit 124: Medtronic Plc - Key news
              • Exhibit 125: Medtronic Plc - Key offerings
              • Exhibit 126: Medtronic Plc - Segment focus
            • 10.11 Pfizer Inc.
              • Exhibit 127: Pfizer Inc. - Overview
              • Exhibit 128: Pfizer Inc. - Product / Service
              • Exhibit 129: Pfizer Inc. - Key news
              • Exhibit 130: Pfizer Inc. - Key offerings
            • 10.12 Teleflex Inc.
              • Exhibit 131: Teleflex Inc. - Overview
              • Exhibit 132: Teleflex Inc. - Business segments
              • Exhibit 133: Teleflex Inc. - Key news
              • Exhibit 134: Teleflex Inc. - Key offerings
              • Exhibit 135: Teleflex Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 136: Inclusions checklist
                • Exhibit 137: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 138: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 139: Research methodology
                • Exhibit 140: Validation techniques employed for market sizing
                • Exhibit 141: Information sources
              • 11.5 List of abbreviations
                • Exhibit 142: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Hemostats and Tissue Sealants market growth will increase by $1496.10 million during 2022-2026.
              The hemostats and tissue sealants market is expected to grow at a CAGR of 9.73% during 2022-2026.
              Technavio has segmented the hemostats and tissue sealants market by product (Hemostats, Tissue sealants and adhesives, and Fibrin sealants) and geographic (North America, Europe, Asia, and ROW).
              Advanced Medical Solutions Group Plc, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CryoLife Inc., Integra LifeSciences Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc., Teleflex Inc. are a few of the key vendors in the hemostats and tissue sealants market.
              North America will register the highest growth rate of 44.71% among the other regions. Therefore, the hemostats and tissue sealants market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the hemostats and tissue sealants market growth are:
              • Use of hemostats and tissue sealants in surgeries
              The hemostats and tissue sealants market vendors should focus on grabbing business opportunities from the hemostats segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single User:

                Quick and easy buy and download option

              • Enterprise:

                Flexible option - Complimentary customization included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>